OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.
This year’s flu outbreak is shaping up to be the worst in a decade. Why does it vary so much season to season?
This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.
Heart disease is the leading cause of death for men in the U.S., killing one in every four males.